A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors.
about
Case Example of Dose Optimization Using Data From Bortezomib Dose-Finding Clinical Trials.Rationally designed treatment for solid tumors with MAPK pathway activation: a phase I study of paclitaxel and bortezomib using an adaptive dose-finding approach.Effect of NF-κB inhibition on chemoresistance in biliary-pancreatic cancer.The 'N-factors' in pancreatic cancer: functional relevance of NF-κB, NFAT and Nrf2 in pancreatic cancer.
P2860
A dose-finding and pharmacodynamic study of bortezomib in combination with weekly paclitaxel in patients with advanced solid tumors.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
A dose-finding and pharmacodyn ...... ts with advanced solid tumors.
@ast
A dose-finding and pharmacodyn ...... ts with advanced solid tumors.
@en
type
label
A dose-finding and pharmacodyn ...... ts with advanced solid tumors.
@ast
A dose-finding and pharmacodyn ...... ts with advanced solid tumors.
@en
prefLabel
A dose-finding and pharmacodyn ...... ts with advanced solid tumors.
@ast
A dose-finding and pharmacodyn ...... ts with advanced solid tumors.
@en
P2093
P2860
P50
P1476
A dose-finding and pharmacodyn ...... ts with advanced solid tumors.
@en
P2093
Amy S Ruppert
Bhuvaneswari Ramaswamy
Charles L Shapiro
David M Lucas
Diedre Wilkins
Donn C Young
Gregory B Lesinski
John J Wright
Kristy Culler
Larry J Schaaf
P2860
P2888
P304
P356
10.1007/S00280-009-1145-Z
P577
2009-09-23T00:00:00Z